Rafarma Pharmaceuticals announced that it has been named one of the four national strategic Pharmaceutical Suppliers to the Russian Federation. This important step for the company means it will receive guaranteed government contracts helping load the manufacturing facility to 100% capacity.
The Russian pharmaceutical industry supplies both the national health care system and hospital sector with 70% of medicines in physical volume. The Russian pharmaceutical market is considered to be one of the most dynamic and growing in the world. It continues to grow an average 10-12% per year since 2003 (Source: The Strategy of Development of the Pharmaceutical Industry of the Russian Federation, http://www.osec.ch/de/filefield-private/files/25703/field_blog_public_files/5244).
CEO David Anderson stated, “This is a very exciting time for the Company and we are extremely happy with the ability to be one of the four national strategic Pharmaceutical Suppliers to the Russian Federation.”
Let us hear your thoughts below: